AccessibilityHelpAbout Us
West Pharmaceutical Services logo

West Pharmaceutical Services(NYSE) WST

Market Cap$23.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1980)+53,209%
5 Year-26%
1 Year+34%
1 Month-4%
Premium Feature
Moneyball Superscore
75/100
$332.90
-1.20%
-4.04Today
West Pharmaceutical Services last closing stock price
MetricPriceDate
Last closeUSD 336.942026-09-09
West Pharmaceutical Services stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.66%USD 342.632026-09-02
1 month-4.31%USD 352.132026-08-10
3 month+2.06%USD 330.122026-06-11
Year to date+22.75%USD 274.502025-12-31
1 year+34.1%USD 251.262025-09-09
3 year-13.56%USD 389.812023-09-08
5 year-25.63%USD 453.042021-09-10
Since inception+53,208.55%USD 0.631980-10-27

West Pharmaceutical Services Financials at a Glance

Market Cap

$23.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.33B

Net Income (TTM)

$564.90M

EPS (TTM)

$7.82

P/E Ratio

43.07

Dividend

$0.88

Beta (Volatility)

0.88 (Low)

Price

$332.90

Volume

144,140.334

Open

$333.57

Previous Close

$336.94

Daily Range

$331.99 - $335.34

52-Week Range

$223.83 - $386.00

Estimated Earnings Date

Oct 22, 2026

WST News

GettyImages-1346518307-1200x800-5b2df79

Billionaire Bill Gates' Foundation Dumped Microsoft but Loaded Up on This Dividend Champion

Thomas NielJun 2, 2026
Child receiving a vaccination shot from a healthcare professional

Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday

Eric VolkmanOct 23, 2025
Foolcom-Featured.png

West Pharma EPS Jumps 22 Percent in Q2

Motley Fool Markets TeamJul 24, 2025
Pharmacist looking in shelves

Why West Pharmaceutical Services Stock Is Heading South Today

Keith SpeightsOct 27, 2022
money gift cash wrapped in bow hundred bill

Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December

James HalleyDec 5, 2020
GettyImages-1181127245

These 2 Under-the-Radar Stocks Could Be Key to Coronavirus Vaccine Distribution

Jason HawthorneNov 1, 2020
GettyImages-1144287268

These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020

Rachel WarrenAug 27, 2020
GettyImages-1141977907

These 10 Stocks Are the Biggest S&P 500 Healthcare Winners of 2020

Zhiyuan SunAug 27, 2020
Page 1

WST: Motley Fool Moneyball Superscore

75

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. makes packaging for injectable medicines. It helps drug companies deliver treatments safely to patients. The company creates stoppers and seals for glass vials.

Essential Medical Packaging

  • Proprietary Products: Packaging and delivery systems for biologics and generic drugs.
  • High-Value Products: Specialized components for complex medicines; organic net sales for components rose 18.4% in the second quarter of 2026.
  • West Vantage: Design and assembly services for complex medical devices; formerly known as the Contract-Manufactured Products segment.
  • Standard Products: Basic glass vial stoppers and seals for general pharmaceutical use.

Strategic Shifts and Sales

  • Agreed to sell the SmartDose 3.5mL On-Body Delivery System to AbbVie in 2026.
  • Increased its ownership interest in Daikyo, a Japanese partner and affiliate.
  • Launched a restructuring plan in January 2025 to optimize the company's legal structure.

Manufacturing Expertise

The company maintains manufacturing sites globally, including locations in the United States and Israel. It differentiates itself through technical expertise in containment systems for biologics, which are complex medicines made from living organisms.

Financial Performance

  • Net sales reached $872.3 million in the three months ended June 30, 2026, up 13.8% year over year.
  • Organic net sales increased 12.7% during the three months ended June 30, 2026; this metric excludes the impact of currency changes and acquisitions.
  • Consolidated gross profit margin was 37.7% in the second quarter of 2026, up 2.0 percentage points year over year.
  • Cash and cash equivalents totaled $435.8 million as of June 30, 2026.

Company Evolution

West has shifted its focus toward high-value proprietary components to serve the growing biologics and GLP-1 markets. This transition strengthens its role as a key supplier for global pharmaceutical manufacturers.

AI Generated • Jul 24, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

10,800

CEO

Eric Mark Green, MBA

Website

www.westpharma.com

Headquarters

Exton, PA 19341-1147, US

WST Financials

Key Financial Metrics (TTM)

Gross Margin

36.77%

Operating Margin

20.64%

Net Income Margin

16.98%

Return on Equity

18.51%

Return on Capital

17.18%

Return on Assets

13.86%

Earnings Yield

2.32%

Dividend Yield

0.26%

Payout Ratio

11.05%

Stock Overview

Market Cap

$23.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.38M

Volume

144.14K

Avg. Volume

689.60K

Financials (TTM)

Gross Profit

$1.22B

Operating Income

$686.50M

EBITDA

$824.20M

Operating Cash Flow

$662.20M

Capital Expenditure

-$225.30M

Free Cash Flow

$436.90M

Cash & ST Invst.

$435.80M

Total Debt

$312.10M

West Pharmaceutical Services Performance Analysis

West Pharmaceutical Services annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,885,500,0001.9%
20232023-12-31USD 2,951,100,0002.3%
20242024-12-31USD 2,892,700,000-2.0%
20252025-12-31USD 3,074,700,0006.3%
West Pharmaceutical Services sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-305.0%
Q42025-12-310.1%
Q12026-03-315.0%
Q22026-06-303.2%
West Pharmaceutical Services annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 7.73-10.9%
20232023-12-31USD 7.882.0%
20242024-12-31USD 6.69-15.2%
20252025-12-31USD 6.791.6%
West Pharmaceutical Services sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-306.0%
Q42025-12-31-5.7%
Q12026-03-315.5%
Q22026-06-3012.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$872.30M

+13.8%

Gross Profit

$329.20M

+20.5%

Gross Margin

37.74%

N/A

Market Cap

$23.71BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.20M

N/A

Employees

10,800

N/A

Net Income

$154.00M

+16.8%

EBITDA

$179.10M

-9.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$435.80M

-14.5%

Total Debt

$312.10M

+2.9%

Accounts Receivable

$712.00M

+22.3%

Inventory

$447.40M

+6.2%

Long Term Debt

$291.20M

+3.1%

Short Term Debt

$20.90M

+0.0%

Return on Assets

13.86%

N/A

Return on Invested Capital

19.98%

N/A

Free Cash Flow

$80.80M

-20.7%

Operating Cash Flow

$124.00M

-30.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INCYIncyte Corporation
$122.85-2.51%
DGXQuest Diagnostics Incorporated
$231.28-1.78%
LHLabcorp Holdings Inc.
$311.38-3.03%
STESTERIS plc
$212.46-1.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$150.81+0.02%
INTCIntel
$101.01-0.05%
NVDANvidia
$218.16-0.02%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.40+0.07%

Questions About WST

What is the current price of West Pharmaceutical Services?

West Pharmaceutical Services is trading at $333.47 per share.

What is the 52-week range for West Pharmaceutical Services?

Over the past 52 weeks, West Pharmaceutical Services has traded between $223.83 and $386.00.

How much debt does West Pharmaceutical Services have?

As of the most recent reporting period, West Pharmaceutical Services reported total debt of $316.50M.

How much cash does West Pharmaceutical Services have on hand?

West Pharmaceutical Services reported $435.80M in cash and cash equivalents in its most recent financial results.

What is West Pharmaceutical Services’s dividend yield?

West Pharmaceutical Services currently has a dividend yield of 0.26%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services